When Gross Total Resection of a Glioblastoma Is Possible, How Much Resection Should Be Achieved?

World Neurosurgery

Volumn 82, Issue 1-2, 2014, Pages e257-e265

  Chaichana, Kaisorn L ^a   Cabrera Aldana, Eibar Ernesto ^a   Jusue Torres, Ignacio ^a   Wijesekera, Olindi ^a   Olivi, Alessandro ^a   Rahman, Maryam ^a   Quinones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extent of resection; GBM; Glioblastoma; Residual; Surgery; Survival; Volumetric

Indexed keywords

CARMUSTINE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; EXTENT OF RESECTION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ONCOLOGICAL PARAMETERS; POSTOPERATIVE RESIDUAL VOLUME; PROGRESSION FREE SURVIVAL; REVIEW; RISK REDUCTION;

EXTENT OF RESECTION; GBM; GLIOBLASTOMA; RESIDUAL; SURGERY; SURVIVAL; VOLUMETRIC;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CONTRAST MEDIA; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEUROSURGICAL PROCEDURES; OBSERVER VARIATION; PATIENT CARE TEAM; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84908237125     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2014.01.019     Document Type: Review

References (38)

1. J.M. Bland, and D.G. Altman Applying the right statistics: analyses of measurement studies Ultrasound Obstet Gynecol 22 2003 85 93
2. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, N.A. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz, and S. Schold Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group Lancet 345 1995 1008 1012
3. J.C. Buckner Factors influencing survival in high-grade gliomas Semin Oncol 30 2003 10 14
4. K. Chaichana, S. Parker, A. Olivi, and A. Quinones-Hinojosa A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme J Neurosurg 112 2010 997 1004
5. K.L. Chaichana, K.K. Chaichana, A. Olivi, J.D. Weingart, R. Bennett, H. Brem, and A. Quinones-Hinojosa Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article J Neurosurg 114 2011 587 594
6. K.L. Chaichana, T. Garzon-Muvdi, S. Parker, J.D. Weingart, A. Olivi, R. Bennett, H. Brem, and A. Quinones-Hinojosa Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients Ann Surg Oncol 18 2011 239 245
7. K.L. Chaichana, A.N. Halthore, S.L. Parker, A. Olivi, J.D. Weingart, H. Brem, and A. Quinones-Hinojosa Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article J Neurosurg 114 2011 604 612
8. K.L. Chaichana, M.J. McGirt, J. Frazier, F. Attenello, H. Guerrero-Cazares, and A. Quinones-Hinojosa Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection J Neurooncol 89 2008 219 224
9. K.L. Chaichana, S.L. Parker, D. Mukherjee, J.S. Cheng, Z.L. Gokaslan, and M.J. McGirt Assessment of the extent of surgical resection as a predictor of survival in patients with primary osseous spinal neoplasms Clin Neurosurg 58 2011 117 121
10. K.L. Chaichana, H. Zaidi, C. Pendleton, M.J. McGirt, R. Grossman, J.D. Weingart, A. Olivi, A. Quinones-Hinojosa, and H. Brem The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival Neurol Res 33 2011 759 764
11. W.J. Curran Jr., C.B. Scott, J. Horton, J.S. Nelson, A.S. Weinstein, A.J. Fischbach, C.H. Chang, M. Rotman, S.O. Asbell, and R.E. Krisch Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
12. W.E. Dandy Removal of right cerebral hemisphere for certain tumors with hemiplegia J Am Med Assoc 90 1928 823 825
13. M. Genc, A.F. Zorlu, and I.L. Atahan Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas Radiother Oncol 56 2000 233 238
14. M.G. Hart, R. Grant, R. Garside, G. Rogers, M. Somerville, and K. Stein Temozolomide for high grade glioma Cochrane Database Syst Rev 2008 CD007415
15. M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, M. Weller, J.M. Kros, J.A. Hainfellner, W. Mason, L. Mariani, J.E. Bromberg, P. Hau, R.O. Mirimanoff, J.G. Cairncross, R.C. Janzer, and R. Stupp MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
16. S.J. Hentschel, and F.F. Lang Current surgical management of glioblastoma Cancer J 9 2003 113 125
17. R.J. Jackson, G.N. Fuller, D. Abi-Said, F.F. Lang, Z.L. Gokaslan, W.M. Shi, D.M. Wildrick, and R. Sawaya Limitations of stereotactic biopsy in the initial management of gliomas Neuro Oncol 3 2001 193 200
18. G.E. Keles, B. Anderson, and M.S. Berger The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere Surg Neurol 52 1999 371 379
19. P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.C. Burger, and W.K. Cavenee The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 61 2002 215 225 [discussion 226-229]
20. M. Lacroix, D. Abi-Said, D.R. Fourney, Z.L. Gokaslan, W. Shi, F. DeMonte, F.F. Lang, I.E. McCutcheon, S.J. Hassenbusch, E. Holland, K. Hess, C. Michael, D. Miller, and R. Sawaya A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2001 190 198
21. K.R. Lamborn, S.M. Chang, and M.D. Prados Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis Neuro Oncol 6 2004 227 235
22. E.R. Laws, I.F. Parney, W. Huang, F. Anderson, A.M. Morris, A. Asher, K.O. Lillehei, M. Bernstein, H. Brem, A. Sloan, M.S. Berger, and S. Chang Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project J Neurosurg 99 2003 467 473
23. P. Linhares, B. Carvalho, R. Figueiredo, R.M. Reis, and R. Vaz Early Pseudoprogression following chemoradiotherapy in glioblastoma patients: The value of RANO evaluation J Oncol 2013 2013 690585
24. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol (Berl) 114 2007 97 109
25. M.J. McGirt, K.L. Chaichana, F.J. Attenello, J.D. Weingart, K. Than, P.C. Burger, A. Olivi, H. Brem, and A. Quinones-Hinojosa Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas Neurosurgery 63 2008 700 707 [author reply 707-708]
26. M.J. McGirt, K.L. Chaichana, M. Gathinji, F.J. Attenello, K. Than, A. Olivi, J.D. Weingart, H. Brem, and A.R. Quinones-Hinojosa Independent association of extent of resection with survival in patients with malignant brain astrocytoma J Neurosurg 110 2009 156 162
27. M.J. McGirt, D. Mukherjee, K.L. Chaichana, K.D. Than, J.D. Weingart, and A. Quinones-Hinojosa Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme Neurosurgery 65 2009 463 469 [discussion 469-470]
28. M.J. McGirt, K.D. Than, J.D. Weingart, K.L. Chaichana, F.J. Attenello, A. Olivi, J. Laterra, L.R. Kleinberg, S.A. Grossman, H. Brem, and A. Quinones-Hinojosa Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme J Neurosurg 110 2009 583 588
29. S.E. Metcalfe, and R. Grant Biopsy versus resection for malignant glioma Cochrane Database Syst Rev 2001 CD002034
30. W.H. Ng, G.Q. Wan, and H.P. Too Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence J Clin Neurosci 14 2007 261 266
31. D. Orringer, D. Lau, S. Khatri, G.J. Zamora-Berridi, K. Zhang, C. Wu, N. Chaudhary, and O. Sagher Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival J Neurosurg 117 2012 851 859
32. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz Jr., J. Hartigan, D.R. Smith, R.L. Strausberg, S.K. Marie, S.M. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
33. Rootsweb: Social Security Index Database. 2013.
34. N. Sanai, M.Y. Polley, M.W. McDermott, A.T. Parsa, and M.S. Berger An extent of resection threshold for newly diagnosed glioblastomas J Neurosurg 115 2011 3 8
35. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018
36. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
37. P.Y. Wen, D.R. Macdonald, D.A. Reardon, T.F. Cloughesy, A.G. Sorensen, E. Galanis, J. Degroot, W. Wick, M.R. Gilbert, A.B. Lassman, C. Tsien, T. Mikkelsen, E.T. Wong, M.C. Chamberlain, R. Stupp, K.R. Lamborn, M.A. Vogelbaum, M.J. van den Bent, and S.M. Chang Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
38. M. Westphal, Z. Ram, V. Riddle, D. Hilt, and E. Bortey Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochir (Wien) 148 2006 269 275 [discussion 275]